BXP: Beximco Pharmaceuticals PLC. - Summary | Jitta

Beximco Pharmaceuticals PLC.

LON:BXP

Price
£0.53
Loss Chance
42.7%
6.34JITTA SCORE
27.85%Under Jitta Line
Jitta Ranking
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (66)
Recent Business Performance (85)
Financial Strength (86)
Return to Shareholders (58)
Competitive Advantage (56)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2022-2025
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.34
27.85%
4.08
96.64%
3.37
155.72%
Pharmaceuticals
1.36
100.00%
6.09
16.73%
6.32
116.41%
COMPANY DESCRIPTION
Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.